IPO Details
Bidding Dates
To be announced
Minimum Investment
To be announced
Price Range
To be announced
Maximum Investment
To be announced
Retail Discount
To be announced
Issue Size
To be announced
Investor category and sub category
Qualified Institutional Buyers | Retail Individual Investors | Non-institutional Investor |About Akums Drugs and Pharmaceuticals Ltd
Established in 2004, Akums Drugs and Pharmaceuticals is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. They own the intellectual property for the manufacturing processes of several formulations, and their core business is focused on providing end-to-end product development and manufacturing solutions to their clients.
Some of their other services include formulation research and development, preparation and filing of regulatory dossiers in the Indian and global markets, and other testing services. In addition to their core CDMO business, they are also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs).
The Indian domestic CDMO market is forecasted to grow at a CAGR of 14.0% between FY 2023 and FY 2028, nearly doubling its historical growth rate. The expansion of this industry will help companies like Akums Drugs and Pharmaceuticals grow.
Akums Drugs and Pharmaceuticals Ltd IPO Details
Akums Drugs and Pharmaceuticals Ltd IPO Dates
The dates for bidding for the Akums Drugs and Pharmaceuticals IPO are yet to be announced.
Akums Drugs and Pharmaceuticals Ltd IPO Price Band
Akums Drugs and Pharmaceuticals is a book-built IPO. The exact price is yet to be announced.
Akums Drugs and Pharmaceuticals Ltd IPO Lot Size
The Akums Drugs and Pharmaceuticals Ltd IPO lot size is not announced yet.
Akums Drugs and Pharmaceuticals Ltd IPO Objectives
The proceeds from the fresh issue will be used for:
- Repayment/ prepayment of indebtedness of the company and its subsidiaries.
- Funding incremental working capital requirements of the company.
- Pursuing inorganic growth initiatives through acquisitions.
- General corporate purposes.
Peer Details
The following are the listed peer companies of Akums Drugs and Pharmaceuticals in India:
- Divi's Laboratories
- Suven Pharma
- Gland Pharma
- Torrent Pharma
- Alkem Laboratories
- Eris Lifesciences
- JB Chemicals
- Mankind Pharma
- Innova Captab
How To Check the Allotment Status of the Akums Drugs and Pharmaceuticals Ltd IPO?
Steps to check IPO allotment status on Angel One’s app:
- Log in to the Angel One app.
- Go to the IPO Section and then to IPO Orders.
- Select the individual IPO that you had applied for and check the allotment status.
- Angel One will notify you of your IPO allotment status via push notification and email.
Contact Details of Akums Drugs and Pharmaceuticals Ltd
Registered office: 304, Mohan Place, LSC Saraswati Vihar, Delhi 110 034, India.
Phone: + 91 11690 41000
E-mail: cs@akums.net
IPO Financials
| Particulars | Year Ending on March 31, 2023 (Amount in ₹ lakhs) | Year Ending on March 31, 2022 (Amount in ₹ lakhs) | Year Ending on March 31, 2021 (Amount in ₹ lakhs) |
|---|---|---|---|
| Total Income | 37,009.25 | 36,945.23 | 27,437.85 |
| Profit (Loss) for the Year | 978.17 | (2,508.74) | 1,234.35 |
| Debt-Equity Ratio | 0.75 | 0.58 | 0.11 |
| Return on Capital Employed | 24.60% | -18.89% | 21.06% |
Know before investing
Strengths
2-
They are the largest India-focused CDMO in terms of revenue, production capacity, and clients served during the Financial Year 2023. The pharmaceutical industry is characterised by significant barriers to entry, notably the high capital expenditure required to establish and maintain sizeable and diverse manufacturing units. Thus, big companies like Akums have an advantage.
-
Their R&D capabilities extend across a diverse range of dosage types, encompassing oral solids, oral liquids, injectables, sterile products, and topicals. Furthermore, their R&D efforts span various product categories, including pharmaceuticals, cosmeceuticals, nutraceuticals and ayurvedic products, among others.
Risks
2-
Their manufacturing units and research and development centres are concentrated in Haridwar, Uttarakhand and are thus exposed to risks originating from economic, regulatory, political and other changes in this region.
-
Any manufacturing or quality control concerns or their inability to deliver products on a timely basis, or at all, could result in the cancellation of purchase orders, breaches of relevant agreements, and termination of agreements by their clients and distributors.
Login to Angel One App / Website & click on IPO
Select desired IPO & tap on "Apply"
Enter UPI ID, set quantity/price & submit
Accept mandate on the UPI app to complete the process
Login to Angel One App / Website
Choose IPO section on Home Page
Click IPO Orders
Chose the IPO application you want to view the status for
Akums Drugs and Pharmaceuticals Ltd IPO FAQs
Akums Drugs and Pharmaceuticals’s IPO is a book-built IPO. The dates for the IPO are yet to be announced.
The date of allotment is not announced yet.
The IPO subscription window is not announced yet.
The lot size for the IPO is yet to be announced.
The listing date for Akums Drugs and Pharmaceuticals is not announced yet.
Listing gains cannot be ascertained before the listing of the IPO on the stock exchange. The date of listing is yet to be announced.
Initially, the bank will only block the amount in your account. The money will not be debited until the stocks are allotted to you.
You must complete the payment process by logging in to your UPI handle and approving the payment mandate.
You can submit only one application using your PAN card.
